Track topics on Twitter Track topics that are important to you
Oct 19 (Reuters) - Britain's GW Pharmaceuticals Plc , a developer of marijuana-based epilepsy treatments, said it planned to cancel its listing in London's junior market and would retain listing of its American Depositary Receipts (ADRs) on Nasdaq t...
Original Article: UPDATE 1-Drug developer GW Pharma to cancel London listingNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...